These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 31737965)

  • 21. Coolmine Therapeutic Community, Dublin: a 40-year history of Ireland's first voluntary drug treatment service.
    Butler S
    Addiction; 2016 Feb; 111(2):197-203. PubMed ID: 26359932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is low threshold methadone maintenance treatment?
    Strike C; Millson M; Hopkins S; Smith C
    Int J Drug Policy; 2013 Nov; 24(6):e51-6. PubMed ID: 23743178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs and Iran after the Islamic revolution: prophesying the next quarter century.
    Spencer C; Agahi C
    Int J Addict; 1990-1991; 25(2A):171-8; discussion 178-9. PubMed ID: 2269552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating Harm Reduction into Outpatient Opioid Use Disorder Treatment Settings : Harm Reduction in Outpatient Addiction Treatment.
    Taylor JL; Johnson S; Cruz R; Gray JR; Schiff D; Bagley SM
    J Gen Intern Med; 2021 Dec; 36(12):3810-3819. PubMed ID: 34159545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran.
    Moradi G; Farnia M; Shokoohi M; Shahbazi M; Moazen B; Rahmani K
    Int J Health Policy Manag; 2015 Mar; 4(9):583-9. PubMed ID: 26340487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selections of reality: applying Burke's dramatism to a harm reduction program.
    Järvinen M; Miller G
    Int J Drug Policy; 2014 Sep; 25(5):879-87. PubMed ID: 24702965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A home for body and soul: substance using women in recovery.
    Kruk E; Sandberg K
    Harm Reduct J; 2013 Dec; 10():39. PubMed ID: 24359089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug abuse in China: past, present and future.
    Lu L; Fang Y; Wang X
    Cell Mol Neurobiol; 2008 Jun; 28(4):479-90. PubMed ID: 17990098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
    Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K
    J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of Substance Abuse and Prevalence of Risk Factors of HIV and Hepatitis among Addicted Women in Western Iran.
    Hamzeh B; Moradi Z; Najafi F; Moradinazar M
    Int J Prev Med; 2019; 10():58. PubMed ID: 31143432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. People with lived and living experience of methamphetamine use and admission to hospital: what harm reduction do they suggest needs to be addressed?
    Forchuk C; Serrato J; Scott L
    Health Promot Chronic Dis Prev Can; 2023 Jun; 43(6):338-347. PubMed ID: 37466399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Policy-Driven HIV Epidemic Among Opioid Users in the Russian Federation.
    Heimer R
    Curr HIV/AIDS Rep; 2018 Jun; 15(3):259-265. PubMed ID: 29671203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks.
    Hyshka E; Anderson-Baron J; Karekezi K; Belle-Isle L; Elliott R; Pauly B; Strike C; Asbridge M; Dell C; McBride K; Hathaway A; Wild TC
    Harm Reduct J; 2017 Jul; 14(1):50. PubMed ID: 28747183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
    Aaraj E; Jreij Abou Chrouch M
    Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Australia's response to HIV among people who inject drugs.
    Madden A; Wodak A
    AIDS Educ Prev; 2014 Jun; 26(3):234-44. PubMed ID: 24846486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating Addictions: Harm Reduction in Clinical Care and Prevention.
    Drucker E; Anderson K; Haemmig R; Heimer R; Small D; Walley A; Wood E; van Beek I
    J Bioeth Inq; 2016 Jun; 13(2):239-49. PubMed ID: 27112489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten years after the United Nations General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposals.
    Reuter P
    Addiction; 2009 Apr; 104(4):510-7. PubMed ID: 19335650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Harm Reduction: Front Line Public Health.
    Stancliff S; Phillips BW; Maghsoudi N; Joseph H
    J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison.
    Small W; Kain S; Laliberte N; Schechter MT; O'Shaughnessy MV; Spittal PM
    Subst Use Misuse; 2005; 40(6):831-43. PubMed ID: 15974143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.